1
|
Meyers PA, Schwartz CL, Krailo M, et al:
Osteosarcoma: a randomized, prospective trial of the addition of
ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and
high-dose methotrexate. J Clin Oncol. 23:2004–2011. 2005.
View Article : Google Scholar : PubMed/NCBI
|
2
|
Bacci G, Forni C, Longhi A, et al: Local
recurrence and local control of non-metastatic osteosarcoma of the
extremities: A 27-year experience in a single institution. J Surg
Oncol. 96:118–123. 2007.PubMed/NCBI
|
3
|
Jawad MU, Cheung MC, Clarke J, et al:
Osteosarcoma: Improvement in survival limited to high-grade
patients only. J Cancer Res Clin Oncol. 137:597–607. 2011.
View Article : Google Scholar : PubMed/NCBI
|
4
|
Mialou V, Philip T, Kalifa C, et al:
Metastatic osteosarcoma at diagnosis: Prognostic factors and
long-term outcome - the French pediatric experience. Cancer.
104:1100–1109. 2005. View Article : Google Scholar : PubMed/NCBI
|
5
|
Hegyi M, Semsei AF, Jakab Z, et al: Good
prognosis of localized osteosarcoma in young patients treated with
limb-salvage surgery and chemotherapy. Pediatr Blood Cancer.
57:415–422. 2011. View Article : Google Scholar : PubMed/NCBI
|
6
|
Stokkel MP, Linthorst MF, Borm JJ, et al:
A reassessment of bone scintigraphy and commonly tested
pretreatment biochemical parameters in newly diagnosed
osteosarcoma. J Cancer Res Clin Oncol. 128:393–399. 2002.
View Article : Google Scholar : PubMed/NCBI
|
7
|
Yeh CS, Wang JY, Cheng TL, et al: Fatty
acid metabolism pathway play an important role in carcinogenesis of
human colorectal cancers by microarray-bioinformatics analysis.
Cancer Let. 233:297–308. 2006. View Article : Google Scholar : PubMed/NCBI
|
8
|
Hess D and Igal RA: Genistein
downregulates de novo lipid synthesis and impairs cell
proliferation in human lung cancer cells. Exp Biol Med (Maywood).
236:707–713. 2011.PubMed/NCBI
|
9
|
Alo PL, Amini M, Piro F, et al:
Immunohistochemical expression and prognostic significance of fatty
acid synthase in pancreatic carcinoma. Anticancer Res.
27:2523–2527. 2007.PubMed/NCBI
|
10
|
Walter K, Hong SM, Nyhan S, et al: Serum
fatty acid synthase as a marker of pancreatic neoplasia. Cancer
Epidemiol Biomarkers Prev. 18:2380–2385. 2009. View Article : Google Scholar : PubMed/NCBI
|
11
|
Okawa Y, Hideshima T, Ikeda H, et al:
Fatty acid synthase is a novel therapeutic target in multiple
myeloma. Br J Haematol. 141:659–671. 2008. View Article : Google Scholar
|
12
|
Migita T, Ruiz S, Fornari A, et al: Fatty
acid synthase: a metabolic enzyme and candidate oncogene in
prostate cancer. J Natl Cancer Inst. 101:519–532. 2009. View Article : Google Scholar : PubMed/NCBI
|
13
|
Liu ZL, Wang G, Shu Y, et al: Enhanced
antitumor activity of epirubicin combined with cerulenin in
osteosarcoma. Mol Med Report. 5:326–330. 2012.PubMed/NCBI
|
14
|
Orita H, Coulter J, Tully E, et al:
Inhibiting fatty acid synthase for chemoprevention of chemically
induced lung tumors. Clin Cancer Res. 14:2458–2464. 2008.
View Article : Google Scholar : PubMed/NCBI
|
15
|
Coleman DT, Bigelow R and Cardelli JA:
Inhibition of fatty acid synthase by luteolin
post-transcriptionally down-regulates c-Met expression independent
of proteosomal/lysosomal degradation. Mol Cancer Ther. 8:214–224.
2009. View Article : Google Scholar : PubMed/NCBI
|
16
|
Saati GE and Archer MC: Inhibition of
fatty acid synthase and Sp1 expression by 3,3′-diindolylmethane in
human breast cancer cells. Nutr Cancer. 63:790–794. 2011.
|
17
|
Notarnicola M, Pisanti S, Tutino V, et al:
Effects of olive oil polyphenols on fatty acid synthase gene
expression and activity in human colorectal cancer cells. Genes
Nutr. 6:63–69. 2011. View Article : Google Scholar : PubMed/NCBI
|
18
|
Notarnicola M, Messa C, Refolo MG, et al:
Polyunsaturated fatty acids reduce fatty acid synthase and
hydroxy-methyl-glutaryl CoA-reductase gene expression and promote
apoptosis in HepG2 cell line. Lipids Health Dis. 10:102011.
View Article : Google Scholar : PubMed/NCBI
|
19
|
Zecchin KG, Rossato FA, Raposo HF, et al:
Inhibition of fatty acid synthase in melanoma cells activates the
intrinsic pathway of apoptosis. Lab Invest. 91:232–240. 2011.
View Article : Google Scholar : PubMed/NCBI
|
20
|
Carvalho MA, Zecchin KG, Seguin F, et al:
Fatty acid synthase inhibition with Orlistat promotes apoptosis and
reduces cell growth and lymph node metastasis in a mouse melanoma
model. Int J Cancer. 123:2557–2565. 2008. View Article : Google Scholar : PubMed/NCBI
|
21
|
Murata S, Yanagisawa K, Fukunaga K, et al:
Fatty acid synthase inhibitor cerulenin suppresses liver metastasis
of colon cancer in mice. Cancer Sci. 101:1861–1865. 2010.
View Article : Google Scholar : PubMed/NCBI
|
22
|
Liu ZL, Zhou Y, Luo QF, et al: Inhibition
fatty acid synthase suppress osteosarcoma cell invasion and
migration. Indian J Pathol Microbiol. 55:163–169. 2012. View Article : Google Scholar
|
23
|
Kim VN, Han J and Siomi MC: Biogenesis of
small RNAs in animals. Nat Rev Mol Cell Biol. 10:126–139. 2009.
View Article : Google Scholar : PubMed/NCBI
|
24
|
Bartel DP: MicroRNAs: target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
25
|
Valencia-Sanchez MA, Liu J, Hannon GJ and
Parker R: Control of translation and mRNA degradation by miRNAs and
siRNAs. Genes Dev. 20:515–524. 2006. View Article : Google Scholar : PubMed/NCBI
|
26
|
Calin GA, Sevignani C, Dumitru CD, et al:
Human microRNA genes are frequently located at fragile sites and
genomic regions involved in cancers. Proc Natl Acad Sci USA.
101:2999–3004. 2004. View Article : Google Scholar : PubMed/NCBI
|
27
|
Sarkar S, Dey BK and Dutta A: MiR-322/424
and -503 are induced during muscle differentiation and promote cell
cycle quiescence and differentiation by down-regulation of Cdc25A.
Mol Biol Cell. 21:2138–2149. 2010. View Article : Google Scholar : PubMed/NCBI
|
28
|
Forrest AR, Kanamori-Katayama M, Tomaru Y,
et al: Induction of microRNAs, mir-155, mir-222, mir-424 and
mir-503, promotes monocytic differentiation through combinatorial
regulation. Leukemia. 24:460–466. 2010. View Article : Google Scholar : PubMed/NCBI
|
29
|
Rosa A, Ballarino M, Sorrentino A, et al:
The interplay between the master transcription factor PU. 1 and
miR-424 regulates human monocyte/macrophage differentiation. Proc
Natl Acad Sci USA. 104:19849–19854. 2007. View Article : Google Scholar : PubMed/NCBI
|
30
|
Nakashima T, Jinnin M, Etoh T, et al:
Down-regulation of mir-424 contributes to the abnormal angiogenesis
via MEK1 and cyclin E1 in senile hemangioma: Its implications to
therapy. PLoS One. 5:e143342010. View Article : Google Scholar : PubMed/NCBI
|
31
|
Chamorro-Jorganes A, Araldi E, Penalva LO,
et al: MicroRNA-16 and microRNA-424 regulate cell-autonomous
angiogenic functions in endothelial cells via targeting vascular
endothelial growth factor receptor-2 and fibroblast growth factor
receptor-1. Arterioscler Thromb Vasc Biol. 31:2595–2606. 2011.
View Article : Google Scholar
|
32
|
Ghosh G, Subramanian IV, Adhikari N, et
al: Hypoxia-induced microRNA-424 expression in human endothelial
cells regulates HIF-α isoforms and promotes angiogenesis. J Clin
Invest. 120:4141–4154. 2010.PubMed/NCBI
|
33
|
Xu J, Li Y, Wang F, et al: Suppressed
miR-424 expression via upregulation of target gene Chk1 contributes
to the progression of cervical cancer. Oncogene. Apr 2–2012.(Epub
ahead of print). View Article : Google Scholar
|
34
|
Faraoni I, Laterza S, Ardiri D, et al:
MiR-424 and miR-155 deregulated expression in cytogenetically
normal acute myeloid leukaemia: correlation with NPM1 and FLT3
mutation status. J Hematol Oncol. 5:262012. View Article : Google Scholar
|
35
|
Rentoft M, Fahlén J, Coates PJ, et al:
miRNA analysis of formalin-fixed squamous cell carcinomas of the
tongue is affected by age of the samples. Int J Oncol. 38:61–69.
2011.PubMed/NCBI
|
36
|
Hussein K, Büsche G, Muth M, et al:
Expression of myelopoiesis associated microRNA in bone marrow cells
of atypical chronic myeloid leukaemia and chronic myelomonocytic
leukaemia. Ann Hematol. 90:307–313. 2011. View Article : Google Scholar
|
37
|
Guo ST, Jiang CC, Wang GP, et al:
MicroRNA-497 targets insulin-like growth factor 1 receptor and has
a tumour suppressive role in human colorectal cancer. Oncogene. Jun
18–2012.(Epub ahead of print). View Article : Google Scholar
|
38
|
Wang X, Wang J, Ma H, et al:
Downregulation of miR-195 correlates with lymph node metastasis and
poor prognosis in colorectal cancer. Med Oncol. 29:919–927. 2012.
View Article : Google Scholar : PubMed/NCBI
|
39
|
Selbach M, Schwanhäusser B, Thierfelder N,
et al: Widespread changes in protein synthesis induced by
microRNAs. Nature. 455:58–63. 2008. View Article : Google Scholar : PubMed/NCBI
|